학술논문
Ex vivo rapamycin generates donor Th2 cells that potently inhibit graft-versus-host disease and graft-versus-tumor effects via an IL-4-dependent mechanism
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
00221767